Transcatheter aortic valve replacement was originally described for the treatment of severe single-valve disease. Advances in technology have opened treatment options for patients with multivalvular pathology (aortic and mitral) with… Click to show full abstract
Transcatheter aortic valve replacement was originally described for the treatment of severe single-valve disease. Advances in technology have opened treatment options for patients with multivalvular pathology (aortic and mitral) with the SAPIEN XT and SAPIEN 3 prostheses. This study describes the
               
Click one of the above tabs to view related content.